Zobrazeno 1 - 10
of 290
pro vyhledávání: '"Mancilla S"'
Autor:
Díaz-Riascos ZV; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain.; Functional Validation & Preclinical Research (FVPR), Unit20 ICTS Nanbiosis, Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain., Llaguno-Munive M; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain., Lafuente-Gómez N; IMDEA Nanociencia, Unidad Asociada al Centro Nacional de Biotecnología (CSIC) 28049 Madrid, Spain., Luengo Y; IMDEA Nanociencia, Unidad Asociada al Centro Nacional de Biotecnología (CSIC) 28049 Madrid, Spain., Holmes S; Nanomedicine and Molecular Imaging group, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin (TCD), Dublin 8 Dublin, Ireland., Volatron J; Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057 CNRS, Université Paris Diderot, Paris 75205, cedex, France., Ibarrola O; BioKeralty Research Institute AIE, 01510 Miñano, Spain., Mancilla S; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain.; Functional Validation & Preclinical Research (FVPR), Unit20 ICTS Nanbiosis, Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain., Sarno F; Grupo de Oncología Traslacional, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain., Aguirre JJ; BioKeralty Research Institute AIE, 01510 Miñano, Spain., Razafindrakoto S; Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057 CNRS, Université Paris Diderot, Paris 75205, cedex, France., Southern P; Resonant Circuits Limited, London W1S 4BS, U.K., Terán FJ; IMDEA Nanociencia, Unidad Asociada al Centro Nacional de Biotecnología (CSIC) 28049 Madrid, Spain.; Unidad Asociada de Nanobiotecnología (CNB-CSIC e IMDEA Nanociencia), 28049 Madrid, Spain.; Unidad de Nanomateriales Avanzados, IMDEA Nanociencia (Unidad de I+D+I Asociada al Instituto de Ciencia de Materiales de Madrid, CSIC), 28049 Madrid, Spain., Keogh A; Department of Histopathology, St. James's Hospital and Trinity College Dublin, Cancer Molecular Diagnostics, Dublin 8 Dublin, Ireland., Salas G; IMDEA Nanociencia, Unidad Asociada al Centro Nacional de Biotecnología (CSIC) 28049 Madrid, Spain.; Unidad Asociada de Nanobiotecnología (CNB-CSIC e IMDEA Nanociencia), 28049 Madrid, Spain.; Unidad de Nanomateriales Avanzados, IMDEA Nanociencia (Unidad de I+D+I Asociada al Instituto de Ciencia de Materiales de Madrid, CSIC), 28049 Madrid, Spain., Prina-Mello A; Nanomedicine and Molecular Imaging group, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin (TCD), Dublin 8 Dublin, Ireland.; Trinity St. James's Cancer Institute, School of Medicine (TCD) and St. James's Hospital, Dublin 8 Dublin, Ireland.; Laboratory for Biological Characterisation of Advanced Materials (LBCAM), TTMI, School of Medicine, Trinity College Dublin, Dublin 8 Dublin, Ireland., Lacal JC; Grupo de Oncología Traslacional, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.; Instituto de Investigaciones Biomédicas (IIB), CSIC, 28029 Madrid, Spain., Del Pozo A; Nanomedicine and Molecular Imaging group, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin (TCD), Dublin 8 Dublin, Ireland., Pankhurst QA; Resonant Circuits Limited, London W1S 4BS, U.K.; Healthcare Biomagnetics Laboratory, University College London, London W1S 4BS, U.K., Hidalgo M; Grupo de Oncología Traslacional, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain., Gazeau F; Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057 CNRS, Université Paris Diderot, Paris 75205, cedex, France., Somoza Á; IMDEA Nanociencia, Unidad Asociada al Centro Nacional de Biotecnología (CSIC) 28049 Madrid, Spain.; Unidad Asociada de Nanobiotecnología (CNB-CSIC e IMDEA Nanociencia), 28049 Madrid, Spain., Schwartz S Jr; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain.; Servei de Bioquímica, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain., Abasolo I; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT), Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain.; Functional Validation & Preclinical Research (FVPR), Unit20 ICTS Nanbiosis, Vall d'Hebron Institute of Research (VHIR), 08035 Barcelona, Spain.; Servei de Bioquímica, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.; Instituto de Química Avanzada de Cataluña (IQAC), CSIC, 08034 Barcelona, Spain.
Publikováno v:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2025 Jan 02. Date of Electronic Publication: 2025 Jan 02.
Autor:
Ziegler, V., Baltzell, N.A., Bossù, F., Carman, D.S., Chatagnon, P., Contalbrigo, M., De Vita, R., Defurne, M., Gavalian, G., Gilfoyle, G.P., Glazier, D.I., Gotra, Y., Gyurjyan, V., Harrison, N., Heddle, D., Hobart, A., Joosten, S., Kim, A., Markov, N., Mancilla, S., Mestayer, M.D., Newton, J., Phelps, W., Niccolai, S., Sokhan, D., Ungaro, M.
Publikováno v:
In Nuclear Inst. and Methods in Physics Research, A 11 April 2020 959
Autor:
Salas O., Ximena1, Mancilla S., Valentina1, Zapata Z., Daniela1, González-Candia, Alejandro2, A. Herrera, Emilio2,3 eherrera@med.uchile.cl
Publikováno v:
Revista ANACEM. 7/1/2017, Vol. 11 Issue 2, p7-12. 6p.
Autor:
González-Callejo P; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain., Gener P; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain., Díaz-Riascos ZV; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Functional Validation & Preclinical Research (FVPR), Vall d‧Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron, Barcelona, Spain., Conti S; Integrative Cell and Tissue Dynamics Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain., Cámara-Sánchez P; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Functional Validation & Preclinical Research (FVPR), Vall d‧Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron, Barcelona, Spain., Riera R; Nanoscopy for Nanomedicine Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.; Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, Netherlands., Mancilla S; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Functional Validation & Preclinical Research (FVPR), Vall d‧Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron, Barcelona, Spain., García-Gabilondo M; Neurovascular Research Laboratory, Vall d‧Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Passeig Vall d'Hebron, Barcelona, Spain., Peg V; Department of Pathology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Arango D; Department of Molecular Oncology, Biomedical Research Institute of Lleida, Lleida, Spain.; Biomedical Research in Digestive Tract Tumors, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron, Barcelona, Spain., Rosell A; Neurovascular Research Laboratory, Vall d‧Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Passeig Vall d'Hebron, Barcelona, Spain., Labernadie A; Integrative Cell and Tissue Dynamics Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain., Trepat X; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Integrative Cell and Tissue Dynamics Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys, Barcelona, Spain., Albertazzi L; Nanoscopy for Nanomedicine Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.; Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, Netherlands., Schwartz S Jr; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain., Seras-Franzoso J; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Department of Genetics and Microbiology, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain., Abasolo I; Drug Delivery & Targeting, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Functional Validation & Preclinical Research (FVPR), Vall d‧Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Passeig de la Vall d'Hebron, Barcelona, Spain.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 May 15; Vol. 152 (10), pp. 2153-2165. Date of Electronic Publication: 2023 Feb 07.
Autor:
González-Mancilla S; DDS, Department of Stomatology, Section of Endodontics, School of Dentistry, University of Sevilla, C/ Avicena s/n, 41009-Sevilla, Spain., Montero-Miralles P; DDS, MSc, PhD, Professor of Master in Clinical Endodontics, University of Sevilla, C/ Avicena s/n, 41009-Sevilla, Spain., Saúco-Márquez JJ; MD, DDS, PhD, Professor of Master in Clinical Endodontics, University of Sevilla, C/ Avicena s/n, 41009-Sevilla, Spain., Areal-Quecuty V; DDS, MSc, Doctoral fellow, University of Sevilla, C/ Avicena s/n, 41009-Sevilla, Spain., Cabanillas-Balsera D; DDS, MSc, PhD, Professor of Master in Clinical Endodontics, University of Sevilla, C/ Avicena s/n, 41009-Sevilla, Spain., Segura-Egea JJ; MD, DDS, PhD, Professor, Department of Stomatology, Section of Endodontics, School of Dentistry, University of Sevilla, C/ Avicena s/n, 41009-Sevilla, Spain.
Publikováno v:
Journal of clinical and experimental dentistry [J Clin Exp Dent] 2022 Nov 01; Vol. 14 (11), pp. e959-e966. Date of Electronic Publication: 2022 Nov 01 (Print Publication: 2022).
Publikováno v:
Revista médica de Chile v.144 n.5 2016
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Handgrip strength is an important predictor of functional performance among older adults. Aim: To measure handgrip strength in older adults and relate its values to their clinical functional assessment. Material and Methods: Handgrip stre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff91bbf60f0437e33d680e9d8433dbd
https://doi.org/10.4067/s0034-98872016000500007
https://doi.org/10.4067/s0034-98872016000500007
Autor:
Fernández Y; Functional Validation & Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Drug Delivery & Targeting Group, CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, 08035, Spain., Movellan J; Polymer Therapeutics Laboratory. Centro de Investigación Príncipe Felipe. Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., Foradada L; Functional Validation & Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Drug Delivery & Targeting Group, CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, 08035, Spain., Giménez V; Polymer Therapeutics Laboratory. Centro de Investigación Príncipe Felipe. Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., García-Aranda N; Functional Validation & Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Drug Delivery & Targeting Group, CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, 08035, Spain., Mancilla S; Functional Validation & Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Drug Delivery & Targeting Group, CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, 08035, Spain., Armiñán A; Polymer Therapeutics Laboratory. Centro de Investigación Príncipe Felipe. Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., Borgos SE; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, NO-7465, Norway., Hyldbakk A; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, NO-7465, Norway., Bogdanska A; Laboratory for Biological Characterization of Advanced Materials (LBCAM), Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, D08 W9RT, Ireland.; Trinity St James's Cancer Institute, Trinity College Dublin, the University of Dublin, Dublin, D08 W9RT, Ireland., Gobbo OL; Trinity St James's Cancer Institute, Trinity College Dublin, the University of Dublin, Dublin, D08 W9RT, Ireland.; School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, D02 R590, Ireland., Prina-Mello A; Laboratory for Biological Characterization of Advanced Materials (LBCAM), Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, D08 W9RT, Ireland.; Trinity St James's Cancer Institute, Trinity College Dublin, the University of Dublin, Dublin, D08 W9RT, Ireland., Ponti J; European Commission, Joint Research Centre (JRC), via Fermi 2749, Ispra, 21027, Italy., Calzolai L; European Commission, Joint Research Centre (JRC), via Fermi 2749, Ispra, 21027, Italy., Zagorodko O; Polymer Therapeutics Laboratory. Centro de Investigación Príncipe Felipe. Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., Gallon E; Polymer Therapeutics Laboratory. Centro de Investigación Príncipe Felipe. Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., Niño-Pariente A; Polymer Therapeutics Laboratory. Centro de Investigación Príncipe Felipe. Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain., Paul A; School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff, CF10 3AT, UK., Schwartz S Jr; Drug Delivery & Targeting Group, CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, 08035, Spain., Abasolo I; Functional Validation & Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Drug Delivery & Targeting Group, CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, 08035, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, 08035, Spain., Vicent MJ; Polymer Therapeutics Laboratory. Centro de Investigación Príncipe Felipe. Av. Eduardo Primo Yúfera 3, Valencia, 46012, Spain.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2022 Apr; Vol. 11 (7), pp. e2101544. Date of Electronic Publication: 2021 Nov 10.
Autor:
Quiroz F., Manuel, Drolett SF., Nicolás, Aguirre P., Paulina, Cifuentes J., Fredi, Mancilla S., Edgardo, Pumarino M., Andrés, Labbé Z., Javier
Publikováno v:
Revista chilena de cirugía, Volume: 70, Issue: 5, Pages: 425-431, Published: 2018
Resumen Introducción: Prolongar la permeabilidad de los injertos utilizados en bypass coronario es un desafío constante. Objetivo: Comparar anatomofuncionalmente venas safenas humanas (VSH) extraídas con técnica convencional (TC) vs técnica “n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______614::5ec27b45a23ae0f9dd7ab415a6338391
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262018000500425&lng=en&tlng=en
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262018000500425&lng=en&tlng=en
Autor:
Quiroz F.,Manuel, Drolett SF.,Nicolás, Aguirre P.,Paulina, Cifuentes J.,Fredi, Mancilla S.,Edgardo, Pumarino M.,Andrés, Labbé Z.,Javier
Publikováno v:
Revista chilena de cirugía v.70 n.5 2018
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Resumen Introducción: Prolongar la permeabilidad de los injertos utilizados en bypass coronario es un desafío constante. Objetivo: Comparar anatomofuncionalmente venas safenas humanas (VSH) extraídas con técnica convencional (TC) vs técnica “n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::5ec27b45a23ae0f9dd7ab415a6338391
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262018000500425
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262018000500425
Publikováno v:
Revista médica de Chile. 143:39-46
Background The Preventive Health Examination of older people in Chile incorporates the timed up and go (TUG) and right and left unipodal stance test (RUPS and LUPS) as functional assessment methods. Aim To assess if TUG and LUPS discriminate older pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aee3879695a36d37b17d265232cbcb63
https://doi.org/10.4067/s0034-98872015000100005
https://doi.org/10.4067/s0034-98872015000100005